A citation-based method for searching scientific literature

Lekha Mikkilineni, James N Kochenderfer. Nat Rev Clin Oncol 2021
Times Cited: 68



Stephen J Schuster, Michael R Bishop, Constantine S Tam, Edmund K Waller, Peter Borchmann, Joseph P McGuirk, Ulrich Jäger, Samantha Jaglowski, Charalambos Andreadis, Jason R Westin, Isabelle Fleury, Veronika Bachanova, S Ronan Foley, P Joy Ho, Stephan Mielke, John M Magenau, Harald Holte, Serafino Pantano, Lida B Pacaud, Rakesh Awasthi, Jufen Chu, Özlem Anak, Gilles Salles, Richard T Maziarz. N Engl J Med 2019
Times Cited: 1457




List of shared articles



Times cited

CAR-NK cells: the next wave of cellular therapy for cancer.
May Daher, Luciana Melo Garcia, Ye Li, Katayoun Rezvani. Clin Transl Immunology 2021
17

Engineering enhanced CAR T-cells for improved cancer therapy.
Michael C Milone, Jie Xu, Sai-Juan Chen, McKensie A Collins, Jianfeng Zhou, Daniel J Powell, J Joseph Melenhorst. Nat Cancer 2021
10

Cancer Immunotherapies: What the Perioperative Physician Needs to Know.
Robert S Ackerman, Aaron R Muncey, Nasrin N Aldawoodi, Rohini Kotha, Rosemarie E Garcia Getting. Curr Oncol Rep 2022
0


Toxicities associated with adoptive cellular therapies.
Doris K Hansen, Marian Dam, Rawan G Faramand. Best Pract Res Clin Haematol 2021
4

Targeting loss of heterozygosity for cancer-specific immunotherapy.
Michael S Hwang, Brian J Mog, Jacqueline Douglass, Alexander H Pearlman, Emily Han-Chung Hsiue, Suman Paul, Sarah R DiNapoli, Maximilian F Konig, Drew M Pardoll, Sandra B Gabelli,[...]. Proc Natl Acad Sci U S A 2021
16

The evolving role of allogeneic haematopoietic cell transplantation in the era of chimaeric antigen receptor T-cell therapy.
Bhagirathbhai Dholaria, Bipin N Savani, Xiao-Jun Huang, Arnon Nagler, Miguel-Angel Perales, Mohamad Mohty. Br J Haematol 2021
6

Preclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell Carcinoma.
Siler H Panowski, Surabhi Srinivasan, Nguyen Tan, Silvia K Tacheva-Grigorova, Bryan Smith, Yvonne S L Mak, Hongxiu Ning, Jonathan Villanueva, Dinali Wijewarnasuriya, Shanshan Lang,[...]. Cancer Res 2022
1

A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains.
Kathryn M Cappell, James N Kochenderfer. Nat Rev Clin Oncol 2021
27


BCMA-targeted therapies for multiple myeloma: strategies to maximize efficacy and minimize adverse events.
Edmund Watson, Faouzi Djebbari, Alexandros Rampotas, Karthik Ramasamy. Expert Rev Hematol 2022
0